[go: up one dir, main page]

PT3589728T - NATURAL KILLER CELLS - Google Patents

NATURAL KILLER CELLS

Info

Publication number
PT3589728T
PT3589728T PT187101258T PT18710125T PT3589728T PT 3589728 T PT3589728 T PT 3589728T PT 187101258 T PT187101258 T PT 187101258T PT 18710125 T PT18710125 T PT 18710125T PT 3589728 T PT3589728 T PT 3589728T
Authority
PT
Portugal
Prior art keywords
natural killer
killer cells
cells
natural
killer
Prior art date
Application number
PT187101258T
Other languages
Portuguese (pt)
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of PT3589728T publication Critical patent/PT3589728T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0646Natural killers cells [NK], NKT cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT187101258T 2017-03-03 2018-03-02 NATURAL KILLER CELLS PT3589728T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1703476.0A GB201703476D0 (en) 2017-03-03 2017-03-03 Natural killer cells

Publications (1)

Publication Number Publication Date
PT3589728T true PT3589728T (en) 2022-09-16

Family

ID=58544022

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187101258T PT3589728T (en) 2017-03-03 2018-03-02 NATURAL KILLER CELLS

Country Status (8)

Country Link
US (2) US11559547B2 (en)
EP (2) EP3589728B1 (en)
JP (2) JP7225107B2 (en)
DK (1) DK3589728T3 (en)
ES (1) ES2928879T3 (en)
GB (1) GB201703476D0 (en)
PT (1) PT3589728T (en)
WO (1) WO2018158587A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201810486D0 (en) * 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells
CN114907333B (en) * 2022-05-11 2023-07-04 中国人民解放军军事科学院军事医学研究院 Cyclopropylamide derivatives, preparation method and application thereof
CN120659871A (en) * 2022-09-02 2025-09-16 帝国理工学院创新有限公司 Natural killer cells
WO2025215203A1 (en) * 2024-04-12 2025-10-16 Institut National de la Santé et de la Recherche Médicale Use of rev-erb antagonists for the treatment of lung infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9121008B2 (en) * 2005-08-31 2015-09-01 University Of Utah Research Foundation Development of natural killer cells and functional natural killer cell lines
US20100267803A1 (en) * 2008-11-07 2010-10-21 The Research Foundation Of State University Of New York Regulators Of Fat Metabolism As Anti-Cancer Targets
CA2785627C (en) 2009-12-29 2020-02-18 Gamida-Cell Ltd. Methods for enhancing natural killer cell proliferation and activity
WO2012128622A1 (en) 2011-03-18 2012-09-27 Ipd-Therapeutics B.V. Generation of nk cells and nk-cell progenitors
WO2013033310A1 (en) 2011-08-31 2013-03-07 Theodore Mark Kamenecka Modulators of rev-erb
US20130330279A1 (en) * 2012-06-09 2013-12-12 Nnanoaxis, Llc Nanoparticle mediated gene therapy, diagnostic products and therapeutic products for breast cancer
ITTO20130816A1 (en) * 2013-10-09 2015-04-10 Fond Istituto Italiano Di Tecnologia REV-ERB ANTARONISTS DIARYLALCHYLAMINES AND THEIR USE AS DRUGS
WO2015103527A1 (en) 2014-01-06 2015-07-09 The Scripps Research Institute Modulators of rev-erb
CN105596336B (en) 2016-01-18 2018-05-22 暨南大学 Compound SR8278 is preparing the application in treating type-1 diabetes mellitus keratopathy drug
US20180280372A1 (en) * 2016-11-22 2018-10-04 Washington University Compositions and methods for inhibiting autophagy and contraception
GB201704953D0 (en) 2017-03-28 2017-05-10 Imp Innovations Ltd Natural killer cells
GB201810486D0 (en) 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells

Also Published As

Publication number Publication date
EP3589728A1 (en) 2020-01-08
EP3589728B1 (en) 2022-09-07
EP4137563A1 (en) 2023-02-22
ES2928879T3 (en) 2022-11-23
DK3589728T3 (en) 2022-09-19
GB201703476D0 (en) 2017-04-19
US11559547B2 (en) 2023-01-24
WO2018158587A1 (en) 2018-09-07
US12496298B2 (en) 2025-12-16
JP7225107B2 (en) 2023-02-20
US20190381102A1 (en) 2019-12-19
JP2023025190A (en) 2023-02-21
JP2020510431A (en) 2020-04-09
US20230330145A1 (en) 2023-10-19

Similar Documents

Publication Publication Date Title
EP3562492A4 (en) GENETICALLY MODIFIED NATURAL KILLER CELLS
IL258666A (en) Natural killer cells and ilc3 cells and their use
IL271227A (en) sensor-like structure
DK3581190T3 (en) MANIPULATED NATURAL KILLER CELLS AND USES THEREOF
EP3858365C0 (en) GOLD-OPTIMIZED CAR-T CELLS
DK3143134T3 (en) Modified, natural killer cells and their uses
EP3443506C0 (en) ARTIFICIAL NERVE CELL
EP3573464A4 (en) B CELL BREEDING
UA38793S (en) BATTERY
CL2020000951A1 (en) Cell.
HUE053760T2 (en) SUV39h1-deficient immune cells
EP3487471A4 (en) BIT-PROOF ARTIFICIAL TITES
EP3358627C0 (en) SOLAR CELL
EP3718392A4 (en) COMBINE
DK3365107T3 (en) CELL CULTURE
EP3720534A4 (en) HUMIDIFIER
EP3613123A4 (en) EFFICIENCY-BASED BATTERY CONFIGURATIONS
EP3448986A4 (en) CELL CULTURE
HUE072082T2 (en) Battery
EP3425626A4 (en) reed
GB201810486D0 (en) Natural killer cells
GB201704953D0 (en) Natural killer cells
IL270880A (en) Cell culture methods
DK3589728T3 (en) Natural killer cells
EP3664201A4 (en) FUEL CELL